We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Vegetables Found to Enhance DNA Repair

By Biotechdaily staff writers
Posted on 21 Feb 2006
A new study reveals that various vegetables contain chemicals that appear to enhance DNA repair in cells, which could lead to protection against the development of cancer.

In a study published in the February 2006 issue of the British Journal of Cancer, investigators demonstrated that in laboratory tests, a compound called indole-3-carinol (I3C), found in broccoli, cauliflower, and cabbage, and a chemical called genistein, found in soy beans, can increase the levels of BRCA1 and BRCA2 proteins that repair damaged DNA.

Although the health benefits of eating vegetables--particularly cruciferous ones, such as broccoli--are not especially new, this study is one of the first to provide a molecular explanation as to how consuming vegetables could slash an individual's risk of developing cancer, an association found by the study's senior author, Eliot M. More...
Rosen, M.D., Ph.D., professor of oncology, cell biology, and radiation medicine at Lombardi Comprehensive Cancer Center at Georgetown University (Washington DC, USA). "It is now clear that the function of crucial cancer genes can be influenced by compounds in the things we eat,” Dr. Rosen noted. "Our findings suggest a clear molecular process that would explain the connection between diet and cancer prevention.”

In this study, Rosen exposed breast and prostate cancer cells to increasing amounts of 13C and genistein, and discovered that these chemicals enhanced production of BRCA1, as well as its sister repair protein, BRCA2. Mutations in either of these genes can lead to development of breast, prostate, and ovarian cancers.

Because decreased amounts of the BRCA proteins are seen in cancer cells, higher levels might prevent cancer from developing, according to Dr. Rosen, adding that the ability of I3C and genistein to increase production of BRCA proteins could explain their protective effects.



Related Links:
Georgetown University

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Pipette Calibration System
Artel PCS®
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.